Director of Teligent: 2012 - present
Mr. Grenfell-Gardner is the President and Chief Executive Officer of Teligent, Inc., where he is leading our transformation into an R&D-centered pharmaceutical company. Prior to joining Teligent in July 2012, Jason spent over eight years at Hikma Pharmaceuticals, PLC and its subsidiaries, including West-Ward Pharmaceuticals in the United States. He served in a number of roles, most recently as SVP of Sales and Marketing, where he led the acquisition of the Baxter sterile injectable facility for West-Ward. Before joining Hikma, Jason worked throughout Central and Eastern Europe as a partner at Trigon Capital, a boutique investment bank, focused on mergers and acquisitions. During his time in that region, Jason served as Chairman of the Board of Sanitas Pharmaceuticals, as well as other board positions. Jason holds an MA (Hons) in Economics from the University of St Andrews in Scotland and an MBA from INSEAD.